Marc Wein
Endocrinologist · Mass General Brigham
Credentials: · · · · ·
History
- Present
- 2012–2014
- 2005–2009
Research
Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease
Review · Clinical Chemistry · 2017 · Last of 3 authors · 269 citations
The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro
Journal of Biological Chemistry · 2015 · 245 citations
RGS9 modulates dopamine signaling in the basal ganglia
Neuron · 2003 · 216 citations
- HK
16 papers
12 papers
- GP
6 papers · 2 as a fellow
- JS
5 papers
4 papers
- DF
3 papers
3 papers · 2 as a resident
3 papers · 2 as a resident
Grants
- 2023–2027
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P50
Contact PI · $6.1M · Massachusetts General Hospital
- 2018–2027
The Role of Salt Inducible Kinases in Parathyroid Hormone Action in Bone
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.8M · Massachusetts General Hospital
- 2015–2020
Dissecting the Roles of Class IIa HDACs in Osteocyte Biology
National Institute of Arthritis and Musculoskeletal and Skin Diseases · K08
Contact PI · $698.1K · Massachusetts General Hospital
- 2018–2020
Reducing Cartilage Destruction in Osteoarthritis with the Small Molecule SIK Inhibitor YKL-05-099
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R03
Contact PI · $167.2K · Massachusetts General Hospital